(Press-News.org) ROCHESTER, Minn. -- Two major drug trials conclude there was little risk from a drug aimed at age-related macular degeneration. Yet a Mayo Clinic ophthalmologist began to note something concerning in some of her patients: an increase in pressure inside the eye. It led to a retrospective study and findings that will be presented at the American Academy of Ophthalmology in Orlando.
Sophie Bakri, M.D., had been treating patients in her clinic with Food and Drug Administration-approved ranibizumab (Lucentis), when she began noticing a change in some patients.
"I was treating patients and measuring pressures, and I was surprised to see that in some of these people, their intraocular pressure was higher, and they didn't have a diagnosis of glaucoma," Dr. Bakri says. "So, why did the pressure go up? Was it from the drug itself, or the actual injection? Is this real? You don't know if it's a fluke unless you go back and look at the clinical trials. I took a closer look at the pooled data."
Intraocular pressure (IOP) is a measure of fluid pressure inside the eye. Measured in millimeters of mercury (mm/Hg), IOP that is higher than normal or above baseline (higher than 21 mm/Hg) can indicate glaucoma.
Data from the two clinical trials in many ways held the answers to Dr. Bakri's questions, but she found that knowing what to look for helps.
MARINA (Minimally Classic/OccultTrial of the Anti-Vascular Endothelial Growth Factor Antibody Ranibizumab in the Treatment of Neovascular Endothelial Age-Related Macular Degeneration) and ANCHOR (Anti-VEGF antibody for the treatment of predominantly classic Choroidal Neovascularization in Age-Related Macular Degeneration) evaluated drugs including Lucentis, for treatment of age-related and other forms of macular degeneration (AMD). Both were
two-year studies with monthly injections of Lucentis, compared to a control group who did not receive the injection. Pooling the two studies, which followed the treatment of 1,125 eyes,
Dr. Bakri was able to perform a more robust evaluation of IOP changes. Some patients received Lucentis and others unknowingly received "sham" or mimicked injections, or a laser treatment called verteporfin photodynamic therapy (PDT), which did not involve injection.
Dr. Bakri found what she suspected: a subset of patients had increased IOP.
"We still don't know if it goes up because of the drug or the pressure of the repeated monthly injections, or both," she says. The take-home finding: intraocular pressure should be monitored in eyes receiving ranibizumab.
"A greater proportion of eyes in the ranibizumab groups had IOP increases regardless of the presence or absence of pre-existing risk factors, such as history of glaucoma, suspicion of glaucoma, ocular hypertension or use of a glaucoma medication," Dr. Bakri says.
A small portion, 8 percent, of all eyes across treatment groups received glaucoma medications in the study. Importantly, none of the patients needed glaucoma surgery.
"Our analysis was surprising because the increase was so prevalent and highly statistically significant," Dr. Bakri says. "Lucentis is an excellent drug that works very well, but if we use a drug, we gain long-term experience, and that's where side effects start showing up.
###
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.mayoclinic.org/about and www.mayoclinic.org/news.
END
(Embargoed) CHAPEL HILL – Research from the University of North Carolina at Chapel Hill suggests that the timing of exposure to UV rays – early in the morning or later in the afternoon – can influence the onset of skin cancer.
The study, performed in mice, found that exposure to UV radiation in the morning increased the risk of skin cancer by 500 percent over identical doses in the afternoon. Although mice and humans both reside on a 24-hour day, the "circadian" clocks of these nocturnal and diurnal creatures run counter each other. This key difference in biology means ...
John W. Coker is a Tennessee auctioneer better known for his sales of fine and decorative art, but when the opportunity arose to handle two outstanding toy and lunchbox collections - each from a collector of 40+ years - he jumped at the chance. More than 100 cardboard boxes later, Coker knew he had the makings of a terrific auction, and one that toy collectors "would go crazy over."
Coker's 1,000-lot Oct. 29-30 event, which will be held at the company's gallery near Knoxville, is 100% unreserved. "Whatever the high bid is, that's what the toy, lunchbox ...
Fetal and neonatal immune thrombocytopenia (FNIT; aka FNAIT) is a condition in which fetuses and newborns have reduced numbers of blood cells known as platelets. Platelets have a key role in blood clotting; if the reduction in platelet number in a fetus or newborn is dramatic, it can lead to bleeding within the skull, which can result in brain damage or even death. A team of researchers led by Heyu Ni, at the University of Toronto, Toronto, has now identified in mice a non-classical form of FNIT that does not cause uncontrolled bleeding within the skull of the fetus/newborn. ...
EDITOR'S PICK: Potential new cause of miscarriage and habitual abortion
Fetal and neonatal immune thrombocytopenia (FNIT; aka FNAIT) is a condition in which fetuses and newborns have reduced numbers of blood cells known as platelets. Platelets have a key role in blood clotting; if the reduction in platelet number in a fetus or newborn is dramatic, it can lead to bleeding within the skull, which can result in brain damage or even death. A team of researchers led by Heyu Ni, at the University of Toronto, Toronto, has now identified in mice a non-classical form of FNIT ...
Having trouble sleeping? If so, you could have a moderately higher risk of having a heart attack, according to research reported in Circulation: Journal of the American Heart Association.
In a recent study, the risk of heart attack in people with insomnia ranged from 27 percent to 45 percent greater than for people who rarely experienced trouble sleeping.
Researchers related heart attack risks to three major insomnia symptoms. Compared to people who reported never or almost never having these problems, people who:
had trouble falling asleep almost daily in the last ...
SEATTLE--Yoga classes were linked to better back-related function and diminished symptoms from chronic low back pain in the largest U.S. randomized controlled trial of yoga to date, published by the Archives of Internal Medicine as an "Online First" article on October 24. But so were intensive stretching classes.
"We found yoga classes more effective than a self-care book—but no more effective than stretching classes," said study leader Karen J. Sherman, PhD, MPH, a senior investigator at Group Health Research Institute. Back-related function was better and symptoms were ...
Various calendar planning, task and resource management as well as reporting tools allow SharePoint users to easily implement project management directly in SharePoint environment.
Virtosoftware presents Virto Project Management - a ready-to-use template based on an extensive set of Virtosoftware components for managing SharePoint projects of various types. Virto Project Management is designed for companies and organizations which want to effectively manage their tasks and resources within SharePoint environment.
The solution integrates several Virtosoftware components ...
Washington, DC (Monday, October 24, 2011) — The most common kidney disease passed down through families, autosomal dominant polycystic kidney disease (ADPKD) affects one in 400 to 1,000 individuals and is characterized by cysts on the kidneys. The condition slowly gets worse and leads to kidney failure.
Most ADPKD cases arise in adults, but some patients show severe symptoms of the disease in early childhood. New research indicates that these severely affected patients carry, in addition to expected inherited genetic defects, further mutations that aggravate the disease.The ...
Biologists at the University of California, San Diego have succeeded in unraveling, for the first time, the complete chain of biochemical reactions that controls the synthesis of auxin, the hormone that regulates nearly all aspects of plant growth and development.
Their discovery, detailed in a paper in this week's online edition of the Proceedings of the National Academy of Sciences, will allow agricultural scientists to develop new ways to enhance or manipulate auxin production to improve the growth and yield of crops and other plants.
More than a century ago, Charles ...
bestwebdesignagencies.com, the independent authority on web design and development, has released their list of the best web strategy companies for the month of October 2011. HypeLife Brands has been named as the fifth best web strategy company, providing services which help customers identify key needs for their online presence ranging from the proper type of website, infrastructure, and miscellaneous needs to make their website a success.
The approach to web strategy which HypeLife Brands allows for a custom solution to be planned out based on the overall vision and ...
